NCT05817331

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire

Qualitative Interviews to Refine and Assess the Importance of Constructs, and Ensure the Readability of Patient, Carer, and Clinician Versions of the Treatment Preference in Myelodysplasia Questionnaire (TPMQ): pTPMQ, cTPMQ, and mTPMQ, Respectively

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 16 (actual)
• Sponsor: Otsuka Australia Pharmaceutical Pty Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary goal of this study is to use qualitative interviews to elicit and confirm concepts related to treatment preferences and understandability of the pTPMQ, cTPMQ, and mTPMQ. The information gathered will be used to support the appropriateness of the questionnaires as a patient-reported, caregiver-reported and clinician-reported outcome measure (PROM) in the population of interest.

Conditions

• Myelodysplastic Syndrome (MDS)

Interventions

Type	Name	Description
OTHER	Carer Treatment Preference Myelodysplasia Questionnaire	Caregiver-reported outcome measure in MDS
OTHER	Clinician Treatment Preference Myelodysplasia Questionnaire	Clinician-reported outcome measure in MDS
OTHER	Patient Treatment Preference Myelodysplasia Questionnaire	Patient-reported outcome measure (PROM) in MDS

Timeline

• Start date: 2022-06-28
• Primary completion: 2023-03-10
• Completion: 2023-03-10
• First posted: 2023-04-18
• Last updated: 2023-04-18

Locations

1 site across 1 country: Australia